Amphiregulin retains ER&#945; expression in acquired aromatase inhibitor resistant breast cancer cells.

Wang, Yuanzhong; Tzeng, Yen-Dun Tony; Chang, Gregory; Wang, Xiaoqiang; Chen, Shiuan

Amphiregulin retains ERα expression in acquired aromatase inhibitor resistant breast cancer cells.

Wang, Yuanzhong; Tzeng, Yen-Dun Tony; Chang, Gregory; Wang, Xiaoqiang; Chen, Shiuan.

Afiliação

Wang Y; Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, California, USA.
Tzeng YT; Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, California, USA.
Chang G; Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Republic of China.
Wang X; Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, California, USA.
Chen S; Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, California, USA.

Endocr Relat Cancer ; 27(12): 671-683, 2020 12.

Article em En | MEDLINE | ID: mdl-33112819

Assuntos

Anfirregulina/uso terapêutico; Inibidores da Aromatase/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Receptor alfa de Estrogênio/metabolismo; Anfirregulina/farmacologia; Inibidores da Aromatase/farmacologia; Neoplasias da Mama/genética; Feminino; Humanos

Palavras-chave

FOXM1; SGK3; endocrine resistance; estrogen receptor; mTOR

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor alfa de Estrogênio / Inibidores da Aromatase / Anfirregulina Limite: Female / Humans Idioma: En Revista: Endocr Relat Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google